findmyKOL

Mohamedtaki Tejani, MD

Basic profile

AdventHealth Orlando

ORCIDNone on fileNPI
RegionOrlando, FL · SoutheastSpecialtyMedical OncologyFocusOncology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mohamedtaki Tejani is an Oncology physician affiliated with AdventHealth Orlando. OpenAlex indexes 125 publications with 3,115 citations (h-index 27).

Overview

Scholarship

indexed output and impact (OpenAlex)
125publications

Distinct works indexed by OpenAlex.

3,115citations

Total citations across indexed works.

27h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

5 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    61.2%
    Opioid Agonist36%
    Oxycodone Hcl39%Morphine Sulfate Er23%Tramadol Hcl14%Oxycodone-Acetaminophen10%Fentanyl9%Hydromorphone Hcl6%
    Part D46 patients
    Phenothiazine11%
    Prochlorperazine Maleate100%
    Part D48 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    27.6%
    Serotonin-3 Receptor Antagonist14.5%
    Ondansetron Hcl83%Ondansetron Odt17%
    Part D<11 patients
    Antidiarrheal microorganisms5.1%
    Creon100%
    Part D<11 patients

    + 3 more classes in this area

  • Sensory organs

    3.8%
    Corticosteroid3.8%
    Dexamethasone100%
    Part D17 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”